Promising early results from a clinical trial at the Mayo Clinic out this week demonstrate that a modified version of the measles virus can be used to target cancer cells and put the condition into remission. Researchers intravenously delivered 10,000 times the typical dosage of measles vaccine to two women, 49- and 65-years-old, who had multiple myeloma, a rare cancer affecting white blood cells in bone marrow. The virus, which was modified to specifically target cancer cells, reduced or eliminated tumors in the two patients. The 49-year-old woman responded particularly well; other than one local relapse that was treated with radiotherapy, her tumors have disappeared and cancer has remained in remission for over six months.
The idea of...
via The Verge - All Posts http://ift.tt/1lBrpRQ
No comments:
Post a Comment